In stocks, Johnson & Johnson JNJ fell more than 1% in early trade despite topping earnings views. The bellwether pharmaceutical and medical products company reported third-quarter sales of $24 billion, beating the estimate of $23.8 billion from analysts polled by FactSet.
Stock Market Today: Dow Sinks As Fed Chief Powell’s Speech Looms; Nvidia Drops (Live Coverage)
view original post